These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24206031)

  • 1. New pharmacotherapy options for cervical cancer.
    Dueñas-Gonzalez A; Cetina L; Coronel J; Cano C; Dolores R
    Expert Opin Pharmacother; 2014 Jan; 15(1):51-60. PubMed ID: 24206031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for the treatment of cervical cancer.
    Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chemotherapy approaches in chemoradiation protocols.
    González-Cortijo L; Carballo N; González-Martín A; Corraliza V; Chiva de Agustín L; Lapuente Sastre F; García García JF; Rojo Sebastián A; Hornedo J; Colomer R
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S45-8. PubMed ID: 18678399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy options for locally advanced and advanced cervical cancer.
    Dueñas-González A; Cetina L; Coronel J; Martínez-Baños D
    Drugs; 2010 Mar; 70(4):403-32. PubMed ID: 20205484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
    Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of drug treatments for cervical cancer.
    Dueñas-González A; Cetina L; Coronel J; González-Fierro A
    Expert Opin Drug Saf; 2016; 15(2):169-80. PubMed ID: 26650333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of current and emerging treatments for cervical cancer.
    Duenas-Gonzalez A; Gonzalez-Fierro A
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):671-682. PubMed ID: 31340683
    [No Abstract]   [Full Text] [Related]  

  • 9. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
    Eifel PJ
    Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
    Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
    Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of bevacizumab with chemotherapy doublets for advanced cervical cancer.
    Krill LS; Tewari KS
    Expert Opin Pharmacother; 2015 Apr; 16(5):675-83. PubMed ID: 25643984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of paclitaxel in the management of patients with carcinoma of the cervix.
    Thigpen T; Vance R; Khansur T; Malamud F
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-41-S2-46. PubMed ID: 9045336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
    Thigpen T; Vance R; Khansur T; Malamud F
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of systemic chemotherapy in metastatic cervical cancer.
    Hogg R; Friedlander M
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):234-40. PubMed ID: 12722882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for cervical cancer.
    Dueñas-Gonzalez A; Cetina L; Coronel J; Cervantes-Madrid D
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):203-18. PubMed ID: 22530838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
    J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
    Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.